BRIEF published on 07/08/2024 at 14:05, 1 year 11 months ago Just – Evotec Biologics étend son partenariat technologique pour les biosimilaires avec Sandoz Partenariat Evotec Biosimilaires Produits Biologiques Sandoz
PRESS RELEASE published on 07/08/2024 at 14:00, 1 year 11 months ago Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz Evotec SE's biologics segment, Just - Evotec Biologics, expands partnership for biosimilars with Sandoz, securing long-term commercial supply. Collaboration aims for cost-efficient development Evotec SE Biosimilars Just - Evotec Biologics Sandoz Commercial Supply
BRIEF published on 06/25/2024 at 07:35, 2 years ago Just-Evotec Biologics Selected by U.S. DOD for Manufacturing Optimization Evotec SE Biologics Manufacturing U.S. Department Of Defense Monoclonal Antibodies Medical Countermeasures
BRIEF published on 06/25/2024 at 07:35, 2 years ago Just-Evotec Biologics sélectionné par le DOD américain pour l'optimisation de la fabrication Evotec SE Fabrication De Produits Biologiques Département Américain De La Défense Des Anticorps Monoclonaux Contre-mesures Médicales
PRESS RELEASE published on 06/25/2024 at 07:30, 2 years ago Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program Just \/ Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program. Evotec SE subsidiary chosen for $39m accelerated mAb development project Evotec SE Just - Evotec Biologics U.S. Department Of Defense Manufacturing Optimization Program MAb Development
BRIEF published on 06/12/2024 at 07:35, 2 years ago Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb Collaboration Neuroscience Evotec Neurodegenerative Diseases Bristol Myers Squibb
BRIEF published on 06/12/2024 at 07:35, 2 years ago Evotec annonce des progrès dans sa collaboration en neurosciences avec Bristol Myers Squibb Collaboration Evotec Maladies Neurodégénératives Neurosciences Bristol Myers Squibb
PRESS RELEASE published on 06/12/2024 at 07:30, 2 years ago Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb Evotec SE makes progress in neuroscience collaboration with Bristol Myers Squibb, receiving a US$20m research payment. The partnership focuses on developing treatments for neurodegenerative diseases Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Collaboration Research Payment
BRIEF published on 06/10/2024 at 18:05, 2 years ago Evotec SE: Results of the Annual General Meeting 2024 Shareholders Supervisory Board Evotec Approval AGM 2024
BRIEF published on 06/10/2024 at 18:05, 2 years ago Evotec SE : Résultats de l'Assemblée Générale Annuelle 2024 Actionnaires Conseil De Surveillance Evotec AGA 2024 Approbation
Published on 06/27/2026 at 16:50, 2 hours 44 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 17 hours 54 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 19 hours 34 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 20 hours 34 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 20 hours 44 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 19 hours 29 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 19 hours 30 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 19 hours 58 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 19 hours 58 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 20 hours 6 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
